Tal Keidar Haran

Tal Keidar Haran

Auto-generated profile, based on publicly available information

Tal Keidar Haran

Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
YLYuzhu Li
Yuzhu Li
NPNir Pillar
Nir Pillar
JLJingxi Li
Jingxi Li
TLTairan Liu
Tairan Liu
DWDi Wu
Di Wu
Aydogan OzcanAydogan Ozcan
Aydogan Ozcan
Traditional histochemical staining of post-mortem samples often confronts inferior staining quality due to autolysis caused by delayed fixation of cadaver tissue, and such chemical staining procedures covering large tissue areas demand substantial labor, cost and time. Here, we demonstrate virtual staining of autopsy tissue using a trained neural network to rapidly transform autofluorescence images of label-free autopsy tissue sections into brightfield equivalent images, matching hematoxylin and eosin (H&E) stained versions of the same samples. The trained model can effectively accentuate nuclear, cytoplasmic and extracellular features in new autopsy tissue samples that experienced severe autolysis, such as COVID-19 samples never seen before, where the traditional histochemical staining fails to provide consistent staining quality. This virtual autopsy staining technique provides a rapid and resource-efficient solution to generate artifact-free H&E stains despite severe autolysis and cell death, also reducing labor, cost and infrastructure requirements associated with the standard histochemical staining.

16 June 2025 in Nature Biomedical Engineering
Verified
Journal Article
Open access
PDF file
LHLuzhe Huang
Luzhe Huang
YLYuzhu Li
Yuzhu Li
NPNir Pillar
Nir Pillar
THTal Keidar Haran
Tal Keidar Haran
WWWilliam Dean Wallace
William Dean Wallace
Aydogan OzcanAydogan Ozcan
Aydogan Ozcan
Histopathological staining of human tissue is essential for disease diagnosis. Recent advances in virtual tissue staining technologies using artificial intelligence alleviate some of the costly and tedious steps involved in traditional histochemical staining processes, permitting multiplexed staining and tissue preservation. However, potential hallucinations and artefacts in these virtually stained tissue images pose concerns, especially for the clinical uses of these approaches. Quality assessment of histology images by experts can be subjective. Here we present an autonomous quality and hallucination assessment method, AQuA, for virtual tissue staining and digital pathology. AQuA autonomously achieves 99.8% accuracy when detecting acceptable and unacceptable virtually stained tissue images without access to histochemically stained ground truth and presents an agreement of 98.5% with the manual assessments made by board-certified pathologists, including identifying realistic-looking images that could mislead diagnosticians. We demonstrate the wide adaptability of AQuA across various virtually and histochemically stained human tissue images. This framework enhances the reliability of virtual tissue staining and provides autonomous quality assurance for image generation and transformation tasks in digital pathology and computational imaging.

25 March 2025 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
RBRaz Ben-Uri
Raz Ben-Uri
LSLior Ben Shabat
Lior Ben Shabat
DSDana Shainshein
Dana Shainshein
OBOmer Bar-Tal
Omer Bar-Tal
YBYuval Bussi
Yuval Bussi
LKLeeat Keren
Leeat Keren

5 November 2025 in Science Translational Medicine
Verified
Journal Article
Closed access
NANofar Azulay
Nofar Azulay
IMIdan Milo
Idan Milo
YBYuval Bussi
Yuval Bussi
RBRaz Ben-Uri
Raz Ben-Uri
THTal Keidar Haran
Tal Keidar Haran
LKLeeat Keren
Leeat Keren
Acute graft-versus-host disease (aGVHD) is a severe complication of allogeneic hematopoietic stem cell transplantation, driven by alloreactive donor T cells in the gut. However, the roles of additional donor and host cells in this process are not fully understood. We conducted multiplexed imaging to generate comprehensive spatial maps of healthy and GVHD-afflicted duodena at single-cell resolution. We profiled 59 biopsies from patients with varying gastrointestinal (GI) aGVHD manifestations and 18 healthy controls and measured the spatial expression of 40 proteins, designated to delineate distinct epithelial cell populations of the gut, stromal cells, and immune cells. Normal duodenum was stereotypical across individuals, showing organization and zonation of epithelial, stromal, and immune cells. Patients with aGVHD exhibited increased fibrosis, alterations in crypt morphology, loss of Paneth cells, and accumulation of endocrine cells in the crypts. Homeostatic immune organization was disrupted, with a prominent reduction in immunoglobulin A–secreting plasma cells. CD8 T cells were enriched only in a subset of patients, whereas others exhibited noncanonical enrichments of macrophages and neutrophils. Immune composition was correlated with the time after transplantation, with shared dynamics observed across individuals. Host cells dominated the plasma and T cell compartments in the gut for extended periods of time after transplantation, suggesting that additional players may drive aGVHD across individuals in addition to donor-derived T cells. This spatial atlas of healthy and GI aGVHD uncovers epithelial and immune dynamics across individuals, offering insights into disease pathophysiology and potential clinical applications.

22 April 2025 in Science Signaling
Verified
Journal Article
Closed access
DGDiana Drago García
Diana Drago García
SGSuvendu Giri
Suvendu Giri
RCRishita Chatterjee
Rishita Chatterjee
ASArturo Simoni
Arturo Simoni
MAMaha Abedrabbo
Maha Abedrabbo
YYYosef Yarden
Yosef Yarden
Cellular plasticity mediates tissue development as well as cancer growth and progression. In breast cancer, a shift to a more epithelial phenotype (epithelialization) underlies a state of reversible cell growth arrest called tumor dormancy, which enables drug resistance, tumor recurrence, and metastasis. Here, we explored the mechanisms driving epithelialization and dormancy in aggressive mesenchymal-like breast cancer cells in three-dimensional cultures. Overexpressing either of the epithelial lineage-associated transcription factors OVOL1 or OVOL2 suppressed cell proliferation and migration and promoted transition to an epithelial morphology. The expression of OVOL1 (and of OVOL2 to a lesser extent) was regulated by steroid hormones and growth factors and was more abundant in tumors than in normal mammary cells. An uncharacterized and indirect target of OVOL1/2, C1ORF116 , exhibited genetic and epigenetic aberrations in breast tumors, and its expression correlated with poor prognosis in patients. We further found that C1ORF116 was an autophagy receptor that directed the degradation of antioxidant proteins, including thioredoxin. Through C1ORF116 and unidentified mediators, OVOL1 expression dysregulated both redox homeostasis (in association with increased ROS, decreased glutathione, and redistribution of the transcription factor NRF2) and DNA damage and repair (in association with increased DNA oxidation and double-strand breaks and an altered interplay among the kinases p38-MAPK, ATM, and others). Because these effects, as they accumulate in cells, can promote metastasis and dormancy escape, the findings suggest that OVOLs not only promote dormancy entry and maintenance in breast cancer but also may ultimately drive dormancy exit and tumor recurrence.

1 May 2022 in Molecular Systems Biology
Verified
Journal Article
Open access
THTal Keidar Haran
Tal Keidar Haran
LKLeeat Keren
Leeat Keren
Twenty years ago, molecular biology transitioned from predominantly studying genes as isolated elements to viewing them as part of complex modules, giving rise to the field of systems biology. This transition was made possible by technological advances that allowed to simultaneously measure the expression levels of thousands of genes in a single experiment and drove a shift toward analyses identifying gene sets, modules, and pathways involved in a biological process of interest. Today we are excitingly facing a similar turning point in cell biology, where single‐cell technologies have enabled us to approach cells as cellular modules.